... remains committed to becoming a global competitor in cutting-edge technologies such as robotics, artificial intelligence and biotechnology by 2025.
News
- Escalating trade dispute looms over Trump, Xi meeting
- New therapies unveiled at San Antonio breast cancer conference
According to the San Antonio Chamber of Commerce's Healthcare + Bioscience Economic Impact Study 2018, the health and bioscience sector ...
- Initial public offerings scheduled to debut next week
Business: Phase 2 biotech targeting acute ischemic stroke and chronic ... Business: Preclinical biotech developing immunotherapies for solid tumors ...
- Fear that uproar over gene-edited babies could block science
But there's significant discomfort, if not complete opposition, to enhancement uses," said Josephine Johnston, an expert on biomedical ethics and ...
- US stocks rise before Trump-Xi trade meeting; oil slips
Biotech drugmaker AbbVie rose 3.8 percent to $93.35 after it said Pfizer agreed to wait until November 2023 before it starts selling a generic version of ...